145 related articles for article (PubMed ID: 28070114)
1. Development of Database and Genomic Medicine for von Hippel-Lindau Disease in Japan.
Takayanagi S; Mukasa A; Nakatomi H; Kanno H; Kuratsu JI; Nishikawa R; Mishima K; Natsume A; Wakabayashi T; Houkin K; Terasaka S; Yao M; Shinohara N; Shuin T; Saito N
Neurol Med Chir (Tokyo); 2017 Feb; 57(2):59-65. PubMed ID: 28070114
[TBL] [Abstract][Full Text] [Related]
2. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
3. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
4. Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition.
Binderup ML; Bisgaard ML; Harbud V; Møller HU; Gimsing S; Friis-Hansen L; Hansen Tv; Bagi P; Knigge U; Kosteljanetz M; Bøgeskov L; Thomsen C; Gerdes AM; Ousager LB; Sunde L;
Dan Med J; 2013 Dec; 60(12):B4763. PubMed ID: 24355456
[TBL] [Abstract][Full Text] [Related]
5. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
6. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology, treatment and follow-up of central nervous system hemangioblastomas in von Hippel-Lindau disease].
Sankaredja J; Brac B; Thines L; Baroncini M; Zairi F; Cardot-Bauters C; Lejeune JP
Rev Neurol (Paris); 2014 Apr; 170(4):288-96. PubMed ID: 24680832
[TBL] [Abstract][Full Text] [Related]
8. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease.
Niemelä M; Lemeta S; Sainio M; Rauma S; Pukkala E; Kere J; Böhling T; Laatikainen L; Jääskeläinen J; Summanen P
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1909-15. PubMed ID: 10845616
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey.
Igarashi H; Ito T; Nishimori I; Tamura K; Yamasaki I; Tanaka M; Shuin T
J Gastroenterol; 2014 Mar; 49(3):511-6. PubMed ID: 23543325
[TBL] [Abstract][Full Text] [Related]
10. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.
Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K
Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570
[TBL] [Abstract][Full Text] [Related]
11. [Current status of clinical diagnosis and DNA test of von Hippel-Lindau disease in Japan].
Shuuin T; Yao M; Kanno H
Gan To Kagaku Ryoho; 1997 Jun; 24(8):938-44. PubMed ID: 9212801
[TBL] [Abstract][Full Text] [Related]
12. Management of von Hippel-Lindau disease-associated CNS lesions.
Wind JJ; Lonser RR
Expert Rev Neurother; 2011 Oct; 11(10):1433-41. PubMed ID: 21955200
[TBL] [Abstract][Full Text] [Related]
13. [The current clinical status of kidney cancers in patients with the VHL disease in Japan: a nationwide epidemiological survey].
Shuin T; Shinohara N; Yao M; Yamasaki I; Tamura K; Kamada M
Nihon Hinyokika Gakkai Zasshi; 2012 May; 103(3):552-6. PubMed ID: 22876660
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
15. Von Hippel-Lindau: Current Evidence in Diagnosis, Treatment, and Nursing Implications.
Zhao K; Barkley TW
Clin J Oncol Nurs; 2015 Dec; 19(6):E121-5. PubMed ID: 26583646
[TBL] [Abstract][Full Text] [Related]
16. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
17. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment.
Shuin T; Yamasaki I; Tamura K; Okuda H; Furihata M; Ashida S
Jpn J Clin Oncol; 2006 Jun; 36(6):337-43. PubMed ID: 16818478
[TBL] [Abstract][Full Text] [Related]
18. von Hippel-Lindau disease: recent advances and therapeutic perspectives.
Richard S;
Expert Rev Anticancer Ther; 2003 Apr; 3(2):215-33. PubMed ID: 12722881
[TBL] [Abstract][Full Text] [Related]
19. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
20. Von Hippel-Lindau disease.
Sano T; Horiguchi H
Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
